Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial

被引：0
作者：
Wojciech Janczyk
Piotr Socha
Dariusz Lebensztejn
Aldona Wierzbicka
Artur Mazur
Joanna Neuhoff-Murawska
Pawel Matusik
机构：
[1] Children’s Memorial Health Institute,Department Gastroenterology, Hepatology and Eating Disorders
[2] Medical University of Bialystok,Department of Pediatrics, Gastroenterology and Allergology
[3] Children's Memorial Health Institute,Laboratory Diagnostics
[4] University of Rzeszow,Medical Faculty
[5] Medical University of Silesia,Departament Pediatric Endocrinology and Diabetes
来源：
BMC Pediatrics | / 13卷
关键词：
Non-alcoholic fatty liver disease; Omega-3 fatty acids; Polyunsaturated fatty acids; Randomized controlled trial; Children;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 298 条
[1]  
Adams LA(2005)The natural history of nonalcoholic fatty liver disease: a population-based cohort study Gastroenterology 129 113-21
[2]  
Lymp JF(2006)Long-term follow-up of patients with NAFLD and elevated liver enzymes Hepatology 44 865-73
[3]  
St Sauver J(2010)Decreased survival of subjects with elevated liver function tests during a 28-year follow-up Hepatology 51 595-602
[4]  
Sanderson SO(2009)Long-term follow-up of patients with nonalcoholic fatty liver Clin Gastroenterol Hepatol 7 234-8
[5]  
Lindor KD(2005)Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease Hepatology 42 473-80
[6]  
Feldstein A(2007)Non-alcoholic fatty liver disease and increased risk of cardiovascular disease Atherosclerosis 191 235-240
[7]  
Angulo P(2008)Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study Am J Gastroenterol 103 2263-71
[8]  
Ekstedt M(2012)Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population Clin Gastroenterol Hepatol 10 646-50
[9]  
Franzén LE(2010)A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease Hepatology 52 79-104
[10]  
Mathiesen UL(2011)Weight reduction for non-alcoholic fatty liver disease Cochrane Database Syst Rev 15 CD003619-66
12345678910